Is Lattice Biologics Ltd halal to invest in?

According to Musaffa's Shariah screening methodology, Lattice Biologics Ltd (LBL.H.V) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Lattice Biologics Ltd a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Lattice Biologics Ltd using these criteria to determine its compliance status.

Can Muslims buy shares of Lattice Biologics Ltd?

Muslim investors may consider investing in Lattice Biologics Ltd if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Lattice Biologics Ltd classified as NOT COVERED?

Musaffa determines the Shariah status of Lattice Biologics Ltd by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Lattice Biologics Ltd updated?

The Shariah compliance status of Lattice Biologics Ltd may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Lattice Biologics Ltd become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Lattice Biologics Ltd?

You can check the latest Shariah compliance status of Lattice Biologics Ltd on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Lattice Biologics Ltd LBL.H.V

€0.04

Last Updated: Jun 03, 12:00 AM·XFRA

Lattice Biologics Ltd. Stock Analysis LBL.H.V

Germany Health Care Nano Cap

Lattice Biologics, Ltd. is a biotech company. The company is headquartered in Belgrade Montana, Montana. The Company’s products are used in a variety of applications including enhancing bone regeneration in dental, spine, and general orthopedic indications. Its acellular dermal matrix is used for dental flaps which is used to close defects post-implantation. The Company’s stem cell-based technology AmnioBoost, is an amniotic fluid concentrate, which can be used to accelerate and enhance bone regeneration for dental post implantation. In addition, its products complimentary to the dental allograft market are amniotic membrane, Demineralized bone matrix (DBM) putty, acellular dermal matrix and cancellous DBM sponges.

Key Statistics of Lattice Biologics Ltd (LBL.H.V)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€0.04€0.04

Today's Open

€0.04

Volume

114.00K

P/E Ratio (TTM)

Market Cap

3.59M

Avg. Volume

Dividend Yield

Financial Metrics & Statements of Lattice Biologics Ltd (LBL.H.V)

FAQ's for Lattice Biologics Ltd (LBL.H.V)

According to Musaffa’s Shariah screening methodology, Lattice Biologics Ltd (LBL.H.V) is currently classified as NOT COVERED as of May 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.